Chemical inhibitors of Sm F can play a role in disrupting the protein's function by intervening in various cellular pathways and processes that are essential for its activity. Amiloride, for example, can inhibit the H+/Na+ exchange, leading to a reduction in cellular pH. This alteration in the intracellular environment can inhibit Sm F's RNA processing activity by deviating from the optimal pH conditions that are essential for its function. Plumbagin targets the NF-kB pathway, which is critical for the expression of proteins that associate with Sm F in the assembly of the spliceosomal complex. By inhibiting this pathway, plumbagin indirectly inhibits the activity of Sm F. Similarly, PD98059 and U0126 both target the MEK/ERK pathway, inhibiting the phosphorylation of proteins that interact with Sm F. This inhibition can impede the formation or function of spliceosomal complexes, thereby inhibiting the activity of Sm F.
Further, LY294002 and Wortmannin, both PI3K inhibitors, can affect the phosphorylation state of spliceosomal proteins, which is crucial for the correct assembly and function of the spliceosome, consequently inhibiting Sm F. The inhibition of RNA processing by 5-Fluorouracil can also indirectly inhibit Sm F, as it disrupts the normal RNA substrates required for Sm F's function in the spliceosome. SB203580 targets p38 MAP kinase, which regulates RNA splicing factors, and its inhibition can lead to the inhibition of Sm F. JNK inhibitor SP600125 disrupts signaling pathways that regulate spliceosome assembly and function, which can inhibit Sm F's role in RNA splicing. Trichostatin A, by altering chromatin structure, can affect the expression of spliceosome-related proteins, indirectly inhibiting Sm F. A-443654's inhibition of Akt disrupts cell survival and protein synthesis pathways, potentially inhibiting interactions necessary for Sm F's activity. Lastly, Rapamycin inhibits mTOR, which plays a role in spliceosomal assembly by influencing the phosphorylation of spliceosomal proteins, and thus can inhibit Sm F's function in RNA splicing.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Amiloride | 2609-46-3 | sc-337527 | 1 g | $296.00 | 7 | |
Amiloride inhibits the H+/Na+ exchange process, which can reduce cellular pH and potentially inhibit Sm F's RNA processing activity by altering the optimal pH conditions required for its function. | ||||||
Plumbagin | 481-42-5 | sc-253283 sc-253283A | 100 mg 250 mg | $52.00 $62.00 | 6 | |
Plumbagin can inhibit the NF-kB pathway, which is crucial for the expression of various proteins including ones that associate with Sm F in spliceosomal complex assembly, thus indirectly inhibiting Sm F activity. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 inhibits MEK, which in turn inhibits ERK phosphorylation. Since ERK is involved in the phosphorylation of proteins that interact with Sm F, this could reduce Sm F's ability to form functional spliceosomal complexes. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 inhibits PI3K, which is part of the signaling pathway that can influence the assembly of spliceosomal complexes, of which Sm F is a component, thereby inhibiting Sm F's function in RNA splicing. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 inhibits MEK1/2, which may be involved in the phosphorylation of spliceosome-related proteins. This inhibition can impede spliceosomal complex formation or function, thereby inhibiting Sm F activity. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $37.00 $152.00 | 11 | |
5-Fluorouracil is incorporated into RNA and disrupts RNA processing and function. By disrupting normal RNA processing, Sm F's role in the spliceosome can be indirectly inhibited due to the lack of proper RNA substrates. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 inhibits p38 MAP kinase, which is involved in cell signaling pathways that regulate RNA splicing factors. Inhibition of this kinase can indirectly lead to the inhibition of Sm F's function in RNA splicing. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a specific inhibitor of PI3K. By inhibiting PI3K, it affects the phosphorylation state of proteins involved in spliceosomal complex assembly, potentially inhibiting Sm F's role in RNA splicing. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 inhibits JNK, which can influence signaling pathways that regulate the spliceosome's assembly and function. Inhibition of JNK can indirectly inhibit Sm F by disrupting these regulatory pathways. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A inhibits histone deacetylases, altering chromatin structure and gene expression. This can indirectly inhibit Sm F by affecting the expression of proteins that interact with Sm F in the spliceosome. | ||||||